Related Experiment Video
Updated: Jul 18, 2026
07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
The endocannabinoid system in ageing: a new target for drug development
A Paradisi1, S Oddi, M Maccarrone
1Department of Biomedical Sciences, University of Teramo, Piazza A. Moro 45, 64100 Teramo, Italy.
Current Drug Targets
|November 15, 2006
Summary
The endocannabinoid system, including anandamide (AEA), modulates aging. Targeting this system with new drugs may treat age-related diseases.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Endocannabinoids are endogenous lipid compounds that interact with cannabinoid receptors.
- Anandamide (AEA) and 2-arachidonoylglycerol are key endocannabinoids, mimicking cannabis effects.
- The endocannabinoid system comprises proteins involved in AEA synthesis, transport, and degradation.
Purpose of the Study:
- To review the endocannabinoid system's characteristics.
- To summarize recent findings on its role in cellular aging.
- To explore therapeutic potential for age-related conditions.
Main Methods:
- Literature review of endocannabinoid research.
- Analysis of studies on aging and the endocannabinoid system.
- Evaluation of therapeutic strategies targeting the endocannabinoid system.
Main Results:
- Endocannabinoids are widely distributed in the central nervous system and peripheral tissues.
- The endocannabinoid system plays a significant role in modulating cellular aging processes.
- Emerging drugs offer potential for treating age-related pathologies by modulating endocannabinoid tone.
Conclusions:
- The endocannabinoid system is a crucial modulator with broad physiological roles.
- Understanding the endocannabinoid system's function in aging is vital for developing new therapies.
- Targeting the endocannabinoid system presents a promising avenue for combating age-related diseases.
More Related Videos
14:25Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...